Overview
Announcements

Ordinary Re-Weighting | Solactive Europe & US Top Pharmaceuticals 2020 AR 3.5% Index | Effective Date 1st July 2024

Solactive Europe & US Top Pharmaceuticals 2020 AR 3.5% Index:

In the ordinary re-weighting, the following composition will be implemented effective open 1st July 2024:

ABBVIE INC
ASTRAZENECA PLC
BRISTOL-MYERS SQUIBB CO
JOHNSON & JOHNSON
MERCK & CO. INC.
NOVARTIS AG
NOVO NORDISK A/S
PFIZER INC
ROCHE HOLDING AG
SANOFI SA